ASPYX
Price
$41.00
Change
+$0.55 (+1.36%)
Updated
Oct 8 closing price
Net Assets
4.46B
RGABX
Price
$79.16
Change
+$0.59 (+0.75%)
Updated
Oct 8 closing price
Net Assets
340.58B
Interact to see
Advertisement

ASPYX vs RGABX

Header iconASPYX vs RGABX Comparison
Open Charts ASPYX vs RGABXBanner chart's image
Alger Spectra Y
Price$41.00
Change+$0.55 (+1.36%)
VolumeN/A
Net Assets4.46B
American Funds Growth Fund of Amer R2
Price$79.16
Change+$0.59 (+0.75%)
VolumeN/A
Net Assets340.58B
ASPYX vs RGABX Comparison Chart in %
View a ticker or compare two or three
VS
ASPYX vs. RGABX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASPYX is a Buy and RGABX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGABX has more cash in the bank: 341B vs. ASPYX (4.47B). ASPYX (0.00) and RGABX (0.00) have matching dividends . ASPYX was incepted earlier than RGABX: ASPYX (7 years) vs RGABX (23 years). RGABX (1.39) is less costly to investors than ASPYX (1.20). ASPYX is a more actively managed with annual turnover of: 49.26 vs. RGABX (25.00). RGABX has a lower initial minimum investment than ASPYX: RGABX (250) vs ASPYX (500000). ASPYX annual gain was more profitable for investors over the last year : 36.79 vs. RGABX (12.92). RGABX return over 5 years is better than : 34.19 vs. ASPYX (29.44).
ASPYXRGABXASPYX / RGABX
Total Expense Ratio1.131.3981%
Annual Report Gross Expense Ratio1.201.3986%
Fund Existence7 years23 years-
Gain YTD31.37419.181164%
Front LoadN/AN/A-
Min. Initial Investment500000250200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.47B341B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year36.7912.92285%
Returns for 3 years145.4569.62209%
Returns for 5 years29.4434.1986%
Returns for 10 yearsN/A88.66-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CCCRX40.05N/A
N/A
Columbia Contrarian Core R
CISMX13.34N/A
N/A
Clarkston Partners Institutional
HSLVX50.48N/A
N/A
Hartford Small Cap Growth R6
HFYTX13.32N/A
N/A
Hartford Schroders Intl Multi-Cp Val R5
TCELX14.27N/A
N/A
T. Rowe Price China Evolution Equity